# Planning and Evaluation

> **NIH NIH P30** · UNIVERSITY OF NEBRASKA MEDICAL CENTER · 2020 · $32,785

## Abstract

Project Summary/Abstract (Description): Planning and Evaluation
The FPBCC Planning and Evaluation applies external and internal assessments of capabilities and
opportunities to the selection and subsequent pursuit of initiatives leading toward fulfillment of the FPBCC
strategic goals and priorities. The external process includes annual convening of a distinguished External
Advisory Board for a review of the FPBCC programs. Internal planning and evaluation includes input from
the Internal Advisory Board, Executive Committee, Senior Leadership Council, and Steering Committee.
Input from FPBCC Members is secured through FPBCC Members' meetings, Research Program meetings,
Multidisciplinary Working Group meetings, the Steering Committee, and an annual retreat. The FPBCC
Grand Rounds, Research Program meetings and Multidisciplinary Working Group meetings routinely provide
opportunities for Members to present and discuss current initiatives and plans for future projects. The FPBCC
Senior Leadership Council consolidates their plans through annual updating the strategic plan. The FPBCC
is well integrated into the broader initiatives of UNMC and Nebraska Medicine, our affiliated clinical enterprise,
through participation of the FPBCC Director on the Chancellor's Council and the Nebraska Medicine Senior
Leadership Team, the two most senior and responsible cabinets within the academic and clinical enterprise
respectively. FPBCC planning and evaluation processes were actively involved in the development of plans for
the new $323 million (M) Buffett Cancer Center cancer research and clinical care facility (625,000 gross
square feet, which is on schedule and on budget for the planned opening in spring 2017. FPBCC planning and
evaluation processes were also important in the targeted priorities for faculty recruitments, the reorganization
of FPBCC Research Programs, enhancements to Shared Resources, identifying and pursuing translational
research opportunities, and investment of developmental funds and institutional resources into strategic
priorities. Examples of capitalizing on the insights of the FPBCC External Advisory Board since the last
review include the targeted recruitment of gastrointestinal cancer and pancreatic cancer researchers and the
establishment of a new FPBCC Gastrointestinal Cancer Program, recruitment of a new Director of the
Bioinformatics Shared Resource (BISR) and enhanced BISR services, recruitment of several FPBCC
faculty to enhance research in drug discovery and drug delivery, and recruitments in genomics/epigenomics
research. FPBCC planning and evaluation processes supported efforts to enhance multi-disciplinary and
transdisciplinary translational research through strategic recruitment and pilot project funding which culminated
in several key multi-project awards to Buffett Cancer Center Members including the NCI P50 SPORE in
Pancreatic Cancer, NCI U01 EDRN Biomarker Discovery for Pancreatic Cancer, NCI U01 Tumor
Microenvironment in P...

## Key facts

- **NIH application ID:** 9981642
- **Project number:** 5P30CA036727-34
- **Recipient organization:** UNIVERSITY OF NEBRASKA MEDICAL CENTER
- **Principal Investigator:** KENNETH H. COWAN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $32,785
- **Award type:** 5
- **Project period:** 1997-09-05 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9981642

## Citation

> US National Institutes of Health, RePORTER application 9981642, Planning and Evaluation (5P30CA036727-34). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9981642. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
